Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System.
Cohen EN, Jayachandran G, Moore RG, Cristofanilli M, Lang JE, Khoury JD, Press MF, Kim KK, Khazan N, Zhang Q, Zhang Y, Kaur P, Guzman R, Miller MC, Reuben JM, Ueno NT. Cohen EN, et al. Among authors: ueno nt. Cancers (Basel). 2022 Oct 26;14(21):5238. doi: 10.3390/cancers14215238. Cancers (Basel). 2022. PMID: 36358657 Free PMC article.
The medical treatment of inflammatory breast cancer.
Dawood S, Ueno NT, Cristofanilli M. Dawood S, et al. Among authors: ueno nt. Semin Oncol. 2008 Feb;35(1):64-71. doi: 10.1053/j.seminoncol.2007.11.012. Semin Oncol. 2008. PMID: 18308147 Review.
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M. De Giorgi U, et al. Among authors: ueno nt. J Clin Oncol. 2009 Jul 10;27(20):3303-11. doi: 10.1200/JCO.2008.19.4423. Epub 2009 May 18. J Clin Oncol. 2009. PMID: 19451443
Molecular targets for treatment of inflammatory breast cancer.
Yamauchi H, Cristofanilli M, Nakamura S, Hortobagyi GN, Ueno NT. Yamauchi H, et al. Among authors: ueno nt. Nat Rev Clin Oncol. 2009 Jul;6(7):387-94. doi: 10.1038/nrclinonc.2009.73. Epub 2009 May 26. Nat Rev Clin Oncol. 2009. PMID: 19468291 Review.
Circulating tumor cells in metastatic inflammatory breast cancer.
Mego M, De Giorgi U, Hsu L, Ueno NT, Valero V, Jackson S, Andreopoulou E, Kau SW, Reuben JM, Cristofanilli M. Mego M, et al. Among authors: ueno nt. Ann Oncol. 2009 Nov;20(11):1824-8. doi: 10.1093/annonc/mdp207. Epub 2009 Jun 25. Ann Oncol. 2009. PMID: 19556320 Free article.
Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer.
Zhang D, LaFortune TA, Krishnamurthy S, Esteva FJ, Cristofanilli M, Liu P, Lucci A, Singh B, Hung MC, Hortobagyi GN, Ueno NT. Zhang D, et al. Among authors: ueno nt. Clin Cancer Res. 2009 Nov 1;15(21):6639-48. doi: 10.1158/1078-0432.CCR-09-0951. Epub 2009 Oct 13. Clin Cancer Res. 2009. PMID: 19825949 Free PMC article.
457 results